197 related articles for article (PubMed ID: 33353384)
1. Cognition and Its Association with Psychosocial and Occupational Functioning during Treatment with Escitalopram in Patients with Major Depressive Disorder: A CAN-BIND-1 Report: La Cognition Et Son Association Avec Le Fonctionnement Psychosocial Et Professionnel Durant Le Traitement Par Escitalopram Chez Des Patients Souffrant De Trouble Dépressif Majeur: Une Étude Can-Bind-1.
McInerney SJ; Chakrabarty T; Maciukiewicz M; Frey BN; MacQueen GM; Milev RV; Ravindran AV; Rotzinger S; Kennedy SH; Lam RW;
Can J Psychiatry; 2021 Sep; 66(9):798-806. PubMed ID: 33353384
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive Brexpiprazole for Patient Life Engagement in Major Depressive Disorder: A Canadian, Phase 4, Open-Label, Interventional Study: Brexpiprazole d'appoint pour l'engagement dans la vie des patients souffrant de trouble dépressif majeur: une étude interventionnelle canadienne ouverte de phase 4.
Therrien F; Ward C; Chokka P; Habert J; Ismail Z; McIntyre RS; MacKenzie EM
Can J Psychiatry; 2024 Jul; 69(7):513-523. PubMed ID: 38425284
[TBL] [Abstract][Full Text] [Related]
3. Cognitive Outcomes with Sequential Escitalopram Monotherapy and Adjunctive Aripiprazole Treatment in Major Depressive Disorder: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report.
Chakrabarty T; McInerney SJ; Torres IJ; Frey BN; Milev RV; Müller DJ; Rotzinger S; Kennedy SH; Lam RW;
CNS Drugs; 2021 Mar; 35(3):291-304. PubMed ID: 33683582
[TBL] [Abstract][Full Text] [Related]
4. The effects of desvenlafaxine on neurocognitive and work functioning in employed outpatients with major depressive disorder.
Lam RW; Iverson GL; Evans VC; Yatham LN; Stewart K; Tam EM; Axler A; Woo C
J Affect Disord; 2016 Oct; 203():55-61. PubMed ID: 27280963
[TBL] [Abstract][Full Text] [Related]
5. The effect of remission status on work functioning in employed patients treated for major depressive disorder.
Sarfati D; Stewart K; Woo C; Parikh SV; Yatham LN; Lam RW
Ann Clin Psychiatry; 2017 Feb; 29(1):11-16. PubMed ID: 27901522
[TBL] [Abstract][Full Text] [Related]
6. Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report.
Kennedy SH; Lam RW; Rotzinger S; Milev RV; Blier P; Downar J; Evans KR; Farzan F; Foster JA; Frey BN; Giacobbe P; Hall GB; Harkness KL; Hassel S; Ismail Z; Leri F; McInerney S; MacQueen GM; Minuzzi L; Müller DJ; Parikh SV; Placenza FM; Quilty LC; Ravindran AV; Sassi RB; Soares CN; Strother SC; Turecki G; Vaccarino AL; Vila-Rodriguez F; Yu J; Uher R;
J Clin Psychiatry; 2019 Feb; 80(2):. PubMed ID: 30840787
[TBL] [Abstract][Full Text] [Related]
7. Cognitive-functional relationships in major depressive disorder: Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram.
Levada OA; Troyan AS
J Affect Disord; 2019 May; 250():114-122. PubMed ID: 30852363
[TBL] [Abstract][Full Text] [Related]
8. Functional outcomes with bright light in monotherapy and combined with fluoxetine in patients with major depressive disorder: Results from the LIFE-D trial.
Li VW; Morton E; Michalak EE; Tam EM; Levitt AJ; Levitan RD; Cheung A; Morehouse R; Ramasubbu R; Yatham LN; Lam RW
J Affect Disord; 2022 Jan; 297():396-400. PubMed ID: 34699857
[TBL] [Abstract][Full Text] [Related]
9. Relationship between work functioning and self-reported cognitive complaints in patients with major depressive disorder treated with desvenlafaxine.
Alonso-Prieto E; Rubino C; Lucey M; Evans VC; Tam EM; Woo C; Iverson GL; Chakrabarty T; Yatham LN; Lam RW
Psychiatry Res; 2019 Feb; 272():144-148. PubMed ID: 30583256
[TBL] [Abstract][Full Text] [Related]
10. A Cognitive Biotype of Depression and Symptoms, Behavior Measures, Neural Circuits, and Differential Treatment Outcomes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Hack LM; Tozzi L; Zenteno S; Olmsted AM; Hilton R; Jubeir J; Korgaonkar MS; Schatzberg AF; Yesavage JA; O'Hara R; Williams LM
JAMA Netw Open; 2023 Jun; 6(6):e2318411. PubMed ID: 37318808
[TBL] [Abstract][Full Text] [Related]
11. Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study.
Chokka P; Bougie J; Proulx J; Tvistholm AH; Ettrup A
CNS Spectr; 2019 Dec; 24(6):616-627. PubMed ID: 30802419
[TBL] [Abstract][Full Text] [Related]
12. Relationship of cognitive impairment with depressive symptoms and psychosocial function in patients with major depressive disorder: Cross-sectional analysis of baseline data from PERFORM-J.
Sumiyoshi T; Watanabe K; Noto S; Sakamoto S; Moriguchi Y; Tan KHX; Hammer-Helmich L; Fernandez J
J Affect Disord; 2019 Nov; 258():172-178. PubMed ID: 31426015
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report.
Morton E; Bhat V; Giacobbe P; Lou W; Michalak EE; McInerney S; Chakrabarty T; Frey BN; Milev RV; Müller DJ; Parikh SV; Rotzinger S; Kennedy SH; Lam RW;
CNS Drugs; 2021 Apr; 35(4):439-450. PubMed ID: 33860922
[TBL] [Abstract][Full Text] [Related]
14. Association between baseline cognitive symptoms and the subsequent presenteeism and global function in patients with major depressive disorder.
Watanabe K; Marumoto T; Ge H; Moriguchi Y; Fujikawa K; Fernandez JL
J Psychiatr Res; 2022 Oct; 154():324-331. PubMed ID: 36027860
[TBL] [Abstract][Full Text] [Related]
15. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder.
Cha DS; Carmona NE; Subramaniapillai M; Mansur RB; Lee Y; Hon Lee J; Lee J; Rosenblat JD; Shekotikhina M; Park C; Rong C; Greer TL; Lam R; Baune BT; Harrison J; McIntyre RS
J Affect Disord; 2017 Nov; 222():14-20. PubMed ID: 28667888
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Early Antidepressant Efficacy in Patients with Major Depressive Disorder Based on Multidimensional Features of rs-fMRI and
Wang T; Gao C; Li J; Li L; Yue Y; Liu X; Chen S; Hou Z; Yin Y; Jiang W; Xu Z; Kong Y; Yuan Y
Can J Psychiatry; 2024 Apr; 69(4):264-274. PubMed ID: 37920958
[TBL] [Abstract][Full Text] [Related]
17. Residual cognitive and psychosocial functional impairment in outpatients in Greece who responded to conventional antidepressant monotherapy treatments for major depressive disorder (MDD).
Papalexi E; Galanopoulos A; Roukas D; Argyropoulos I; Michopoulos I; Douzenis A; Gkolia I; Fotiadis P; Kontis D; Zervas IM
J Affect Disord; 2022 Oct; 314():185-192. PubMed ID: 35817305
[TBL] [Abstract][Full Text] [Related]
18. A new clinical rating scale for work absence and productivity: validation in patients with major depressive disorder.
Lam RW; Michalak EE; Yatham LN
BMC Psychiatry; 2009 Dec; 9():78. PubMed ID: 19958540
[TBL] [Abstract][Full Text] [Related]
19. Association between discrepancy in objective and subjective cognitive abilities and treatment response in patients with major depressive disorder: A CAN-BIND-1 study report.
Rnic K; Jung YE; Torres I; Chakrabarty T; LeMoult J; Vaccarino AL; Morton E; Bhat V; Giacobbe P; McInerney S; Frey BN; Milev RV; Müller D; Ravindran AV; Rotzinger S; Kennedy SH; Lam RW;
J Affect Disord; 2021 Dec; 295():1095-1101. PubMed ID: 34706420
[TBL] [Abstract][Full Text] [Related]
20. Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report.
Chakrabarty T; Harkness KL; McInerney SJ; Quilty LC; Milev RV; Kennedy SH; Frey BN; MacQueen GM; Müller DJ; Rotzinger S; Uher R; Lam RW
Psychol Med; 2020 Nov; 50(15):2536-2547. PubMed ID: 31583989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
